Omega-3-Ulei de Peste
Ulei de Peste cu: Omega 3 EPA/DHA
1. Asociatia nivelului de Omega-3 Ulei de Peste reduce rata de
scurtare a telomerilor la pacientii cu boala coronariana
2. Omega-3 Ulei de Peste cu EPA/DHA atenua cresterile legate
de varsta, in
rigiditatea arteriala la pacientii cu dislipidemie
3. Ulei de peste cu continutul de acizii grasi cu catena lunga eicosapentaenoic
(EPA; 20:5n-3) si docosahexaenoic (DHA; 22:6n-3) sunt componenti de
baza al uleiului de peste, importanti in dezvoltarea timpurie a copiilor,
in principal
a tesuturilor neurale si cresterea capacitatii de memorare la copii.
4.
Ulei de Peste Ulei de peste si uleiul vegetal inhiba producerea de
citokine proinflamatorii, a interleukina-1 (IL-1) si factorul de necroza
tumorala-alfa (TNF-alfa).
Ulei
de peste Omega 3 EPA/DHA
Structura chimica:
Acid alfa-linolenic (ALA; 18:3n-3),
Acid eicosapentaenoic (EPA; 20:5n-3)
Acid docosahexaenoic (DHA; 22:6n-3)
Acizi grasi polinesaturati Omega 3 - EPA/DHA
5. Uleiul
de peste cu continutul de acid eicosapentaenoic si docosahexaenoic inhiba
activitatea cascadei acidului arahidonic de ciclooxigenaza (COX-2),
lipoxigenaza , prostaglandine, leucotriene, moduleaza
inflamatia articulara, si leziuni distructive din artrita reumatoida
| Uleiul de peste moduleaza inflamatia articulara |
 |
6. Uleiul
de peste indicat la discogena lombara o alternativa la AINS
(Antiinflamatoarele nesteroidiene)
7. Uleiul
de peste cu continutul de omega 3 EPA/DHA moduleaza factorul catabolic
a cartilagiului articular
8. Efectul
uleiului de peste dupa sistarea AINS (Antiinflamatoarele nesteroidiene)
in tratamentul artritei reumatoide
9. Uleiul
de peste cu continutul de omega 3 EPA/DHA si naproxen in tratamentul
artritei reumatoide
10. Suplimente
nutritive cu ulei de peste in artrita
reumatoida, studii randomizat, dublu orb,
placebo controlat
11. Uleiul
de peste reduce nivelul sangvin al colesterolului
12. Uleiul
de peste reduce vascozitatea sangelui scade hipertensiunea
13. Uleiul
de peste cu continutul de omega 3 EPA/DHA indicat la ateroscleroza reduce
placa aterosclerotica
14. Tratamentul
cu ulei de peste in principalele boli cardiovasculare
15. Uleiul
de peste cu continutul de omega 3 EPA/DHA un foarte important modulator
nutritional in bolile coronariene
16. Uleiul
de peste este un bun antiagregant, antigoagulant
17. Uleiul
de peste o apetisanta alternativa la anti-aritmice
18. Uleiul
de peste si Vitamina E indicat dupa infarctul miocardic
19. Suplimente
cu Vitamine, medicina herbala, indicat la aritmie - Activitatea de
Ulei de peste Omega - 3, Coenzima Q10, si Carnitina cu derivatii
sai reduce moartea subita dupa infarctul miocardic.
20. Uleiul
de peste cu continutul de acizi grasi polinesaturati n-3 are protectie
de moarte subita dupa infarctul miocardic
21. Uleiul
de peste imbunatateste vederea mareste acuitatea vizuala
22. Uleiul
de peste indicat in timpul sarcinii sau perioadei de alaptare
23. Uleiul
de peste indicat la colita ulceroasa
24. Uleiul
de peste trateaza diabetul zaharat care nu este dependent de insulina
25. Uleiul
de peste fiind recomandat in terapia de hiperactivitate
26. Uleiul
de peste important pentru dezvoltarea timpurie a sistemului nervos
| Uleiul de peste cu continutul de EPA/DHA ajuta la prevenirea de declin
cognitiv la pacienti cu Alzheimer |
 |
27. Uleiul
de peste indicat in tratamentul depresie si schizofrenie
28. Uleiul
de peste cu continutul de omega 3 EPA/DHA are efect anti cancer
| Uleiul de peste cu continutul de omega 3 EPA/DHA are
efect anti cancer |
 |
Acizi
grasi polinesaturati Omega 3 - Epa/DHA -
in diferite alimente
29. Ulei de Peste cu efect de mediere la celulele stem
din maduva osoasa care genereaza celule progenitoare
30. Ulei de Peste cu impact hematopeietic la refacerea
hematopoiezei prin reducerea celulelelor progenitoare mieloide din
maduva osoasa
31. Ulei de Peste Omega 3 cu potential de folosinta
in terapia de cahexia indusa de cancer
| Bibliografie-Referinte: |
 |
1. Farzaneh-Far R, Lin J, Epel ES, Harris WS, Blackburn EH, Whooley
MA. Association of marine omega-3 fatty acid levels with telomeric
aging in patients with coronary heart disease. Division of Cardiology,
Room 5G1, San Francisco General Hospital, 1001 Potrero Ave, San Francisco,
CA 94110, USA. JAMA. 2010 Jan 20;303(3):250-7.
2. Tomiyama H, Takazawa K, Osa S, et al. Do eicosapentaenoic acid supplements
attenuate age-related increases in arterial stiffness in patients with dyslipidemia?
a preliminary study. Hypertens Res. 2005; 28(8):651-655.
3. Gibson
RA, Neumann MA, Makrides M. Effect of dietary docosahexaenoic acid on
brain composition and neural function in term infants. Lipids 1996;31:177S-81S,
- Makrides
M, Neumann MA, Simmer K, Gibson RA. A critical appraisal of the role
of dietary long-chain polyunsaturated fatty acids on neural indices of
term infants: a
randomized, controlled trial. Pediatrics 2000;105:32-8.,
- Makrides
M, Neumann MA, Gibson RA. Is dietary docosahexaenoic acid essential for
term infants Lipids 1996;31:115-9.
4. Brenna JT. Efficiency
of conversion of alpha-linolenic acid to long chain n-3 fatty acids in
man. Curr Opin Clin Nutr Metab Care. 2002;5(2):127-132.
- Caughey
GE, et al. The effect on human tumor necrosis factor alpha and interleukin
1 beta production of diets enriched in n-3 fatty acids from vegetable
oil or fish oil. Am J Clin Nutr 1996 Jan;63(1):116-22
- Lo
CJ, et al., Fish Oil Decreases Macrophage Tumor Necrosis Factor Gene
Transcription by Altering the NFkappaB Activity. J Surg Res 1999 Apr;82(2):216-221
- Kremer
JM, et al. Dietary fish oil and olive oil supplementation in patients
with rheumatoid arthritis. Clinical and immunologic effects. Arthritis
Rheum 1990
Jun;33(6):810-20
5. Khalfoun B, et al., Docosahexaenoic and eicosapentaenoic acids inhibit
in vitro human endothelial cell production of interleukin-6. Adv Exp
Med Biol 1997;400B:589-97
- Terano
T, et al. Eicosapentaenoic acid as a modulator of inflammation. Effect
on prostaglandin and leukotriene synthesis. Biochem Pharmacol 1986
Mar 1;35(5):779-85
-R aederstorff
D, et al. Anti-inflammatory properties of docosahexaenoic and eicosapentaenoic
acids in phorbol-ester-induced mouse ear inflammation. Int Arch Allergy
Immunol 1996 Nov;111(3):284-90
- Mayatepek
E, et al. Influence of dietary (n-3)-polyunsaturated fatty acids on leukotriene
B4 and prostaglandin E2 synthesis and course of experimental tuberculosis
in guinea pigs. Infection 1994 Mar-Apr;22(2):106-12
- Khalfoun
B, et al. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro
human lymphocyte-endothelial cell adhesion. Transplantation 1996 Dec
15;62(11):1649-57
6. Maroon JC. ù-3 Fatty acids (fish
oil) as an anti-inflammatory: an alternative to nonsteroidal anti-inflammatory
drugs for discogenic pain.
Surgical Neurology 2006; 65(4): 326-331
7. Saklatvala J. Tumour necrosis factor
alpha stimulates resorption and inhibits synthesis of proteoglycan in
cartilage. Nature 1986 Aug 7-13;322 (6079):547-9
- Curtis CL, et al. n-3 fatty acids specifically modulate catabolic factors involved
in articular cartilage degradation. J Biol Chem 2000 Jan 14;275(2):721-4
- Espersen GT, et al. Decreased interleukin-1 beta levels in plasma from rheumatoid
arthritis patients after dietary supplementation with n-3 polyunsaturated fatty
acids. Clin Rheumatol 1992 Sep;11(3):393-5
- Venkatraman JT, et al. Effects of dietary omega-3 and omega-6 lipids and vitamin
E on serum cytokines, lipid mediators and anti-DNA antibodies in a mouse model
for rheumatoid arthritis. J Am Coll Nutr 1999 Dec;18(6):602-13
8. Lau CS, et al. Effects
of fish oil supplementation on non-steroidal anti-inflammatory drug requirement
in patients with mild rheumatoid arthritis-a double-blind placebo controlled
study. Br J Rheumatol 1993 Nov;32(11):982-9
- Kremer JM, et al. Effects of high-dose fish oil on rheumatoid arthritis after
stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates.
Arthritis Rheum 1995 Aug;38(8):1107-14
9. Kjeldsen-Kragh J, et al. Dietary
omega-3 fatty acid supplementation and naproxen treatment in patients
with rheumatoid arthritis. J Rheumatol 1992 Oct;19(10):1531-6
10. Kremer JM. n-3
fatty acid supplements in rheumatoid arthritis. Am J Clin Nutr 2000 Jan;71(1
Suppl): 349S-51S
- Kremer JM, et al. Fish-oil fatty acid supplementation in active rheumatoid
arthritis. A double-blinded, controlled, crossover study. Ann Intern Med 1987
Apr;106(4):497-503
- Skoldstam L, et al. Effect of six months of fish oil supplementation in stable
rheumatoid arthritis. A double-blind, controlled study. Scand J Rheumatol 1992;21(4):178-85
- Faarvang KL, et al. [Fish oils and rheumatoid arthritis. A randomized and double-blind
study]. Ugeskr Laeger 1994 Jun 6;156(23):3495-8
- Nielsen GL, et al. The effects of dietary supplementation with n-3 polyunsaturated
fatty acids in patients with rheumatoid arthritis: a randomized, double blind
trial. Eur J Clin Invest 1992 Oct;22(10):687-91
- van der Tempel H, et al. Effects of fish oil supplementation in rheumatoid
arthritis. Ann Rheum Dis 1990 Feb;49(2):76-80
- Fortin PR, Lew RA, Liang MH, et al. Validation
of a meta-analysis: the effects of fish oil in rheumatoid arthritis. J Clin
Epidemiol. 1995;48(11):1379-1390.
- Cleland LG, et al.Clinical and biochemical effects of dietary fish oil supplements
in rheumatoid arthritis. J Rheumatol 1988 Oct;15(10):1471-5
- James MJ, et al. Dietary polyunsaturated fatty acids and inflammatory mediator
production. Am J Clin Nutr 2000 Jan;71(1 Suppl):343S-8S
11. Harris WS. n-3
fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65(5
Suppl):1645S-1654S.
- Adler AJ, Holub BJ. Effect of garlic and fish-oil supplementation on serum
lipid and lipoprotein concentrations in hypercholesterolemic men. Am J Clin Nutr
1997;65:445-50
12. Toft I, Bonaa KH, Ingebretsen OC,
et al. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis
and blood pressure in essential hypertension. Ann Intern Med 1995;123:911-8.
13. Sacks FM, Stone PH, Gibson CM,
Silverman DI, Rosner B, Pasternak RC. Controlled
trial of fish oil for regression of human coronary atherosclerosis. HARP
Research Group. J Am Coll Cardiol. 1995;25(7):1492-1498.
- von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H. The
effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized,
double-blind, placebo-controlled trial. Ann Intern Med. 1999;130(7):554-562.
14. Bucher HC, Hengstler P, Schindler
C, Meier G. N-3
polyunsaturated fatty acids in coronary heart disease: a meta-analysis of
randomized controlled trials. Am J Med. 2002;112(4):298-304.
- Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3
fatty acids, and cardiovascular disease. Circulation. 2002;106(21):2747-2757.
- Leaf A, Weber PC. Cardiovascular effects of n-3 fatty acids. N Engl J Med 1988;318:549-57.
- Kris-Etherton PM, Harris WS, Appel LJ. Omega-3 fatty acids and cardiovascular
disease: new recommendations from the American Heart Association. Arterioscler
Thromb Vasc Biol. 2003;23(2):151-152.
15. Harris WS. Are
omega-3 fatty acids the most important nutritional modulators of coronary
heart disease risk St. Luke's Mid America Heart Institute and Department
of Medicine, University of Missouri-Kansas City School of Medicine,
4320 Wornall Road, Suite 128, Kansas City, MO 64111, USA. wharris@saint-lukes.org
Curr Atheroscler Rep. 2004 Nov;6(6):447-52.
16. Nelson GJ, Schmidt PS, Bartolini
GL, et al. The effect of dietary docosahexaenoic acid on platelet function,
platelet fatty acid composition, and blood coagulation in humans. Lipids
1997;32:1129-36.
17. Albert C. Fish
oil--an appetising alternative to anti-arrhythmic drugs Division of Preventive
Medicine, Brigham and Women's Hospital, and Cardiology Division, Massachusetts
General Hospital, Boston, MA 02215, USA. calbert@partners.org Lancet.
2004 May 1;363(9419):1412-3.
18. Dietary
supplementation with n-3 polyunsaturated fatty acids and vitamin E after
myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo
Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet.
1999;354(9177):447-455
19. Chung MK. Vitamins,
supplements, herbal medicines, and arrhythmias. Department of Cardiovascular
Medicine, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
chungm@ccf.org
20. Marchioli R, Barzi F, Bomba E,
Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi
G, Maggioni AP, Mantini L, Marfisi RM,
Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi
L, Tognoni G, Tucci C, Valagussa F; GISSI-Prevenzione Investigators.
Early protection against sudden death by n-3 polyunsaturated fatty
acids after myocardial infarction: time-course analysis of the results
of the
Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico
(GISSI)-Prevenzione.
Department of Clinical Pharmacology and Epidemiology, Consorzio Mario
Negri Sud, Santa Maria Imbaro, Chieti, Italy. marchioli@negrisud.it
Circulation. 2002 Apr 23;105(16):1897-903.
21. Carlson SE, Werkman SH, Rhodes
PG, Tolley EA. Visual-acuity
development in healthy preterm infants: effect of marine-oil supplementation.
Am J Clin Nutr. 1993;58(1):35-42.
- Carlson SE, Werkman SH, Tolley EA. Effect
of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm
infants with and without bronchopulmonary dysplasia. Am J Clin Nutr. 1996;63(5):687-697.
- Faldella G, Govoni M, Alessandroni R, et al. Visual
evoked potentials and dietary long chain polyunsaturated fatty acids in preterm
infants. Arch Dis Child Fetal Neonatal Ed. 1996;75(2):F108-112.
- O'Connor DL, Hall R, Adamkin D, et al. Growth
and development in preterm infants fed long-chain polyunsaturated fatty acids:
a prospective, randomized controlled trial. Pediatrics. 2001;108(2):359-371.
- SanGiovanni JP, Parra-Cabrera S, Colditz GA, Berkey CS, Dwyer JT. Meta-analysis
of dietary essential fatty acids and long-chain polyunsaturated fatty acids as
they relate to visual resolution acuity in healthy preterm infants. Pediatrics.
2000;105(6):1292-1298.
- Jeffrey BG, Weisingerb HS, Neuringer M, Mitcheli DC. The
role of docosahexaenoic acid in retinal function. Lipids. 2001;36(9):859-871.
22. Gibson RA, Chen W, Makrides M. Randomized
trials with polyunsaturated fatty acid interventions in preterm and term
infants:
functional and clinical outcomes. Lipids. 2001;36(9):873-883.
- Simmer K. Longchain
polyunsaturated fatty acid supplementation in infants born at term. Cochrane
Database Syst Rev. 2001(4):CD000376. (PubMed)
- Makrides M, Gibson RA. Long-chain
polyunsaturated fatty acid requirements during pregnancy and lactation. Am
J Clin Nutr. 2000;71(1 Suppl):307S-311S.
200-400mg epa/zi
23. Aslan A, Triadafilopoulos
G. Fish
oil fatty acid supplementation in active ulcerative colitis: a double-blind,
placebo-controlled, crossover study. Am J Gastroenterol. 1992;87(4):432-437.
- Lorenz R, Weber PC, Szimnau P, Heldwein W, Strasser T, Loeschke K. Supplementation
with n-3 fatty acids from fish oil in chronic inflammatory bowel disease
a randomized, placebo-controlled, double-blind cross-over trial. J Intern
Med Suppl. 1989;225(731):225-232.
24. Friedberg
CE, Janssen MJ, Heine RJ, Grobbee DE. Fish
oil and glycemic control in diabetes. A meta-analysis. Diabetes Care. 1998;21(4):494-500
- Malasanos TH, Stacpoole PW. Biological effects of omega-3 fatty acids in diabetes
mellitus. Diabetes Care 1991;14:1160-79.,
- Schectman G, Kaul S, Kassebah AH. Effect of fish oil concentrate on lipoprotein
composition in NIDDM. Diabetes 1988;37:1567-73.,
- Dunstan DW, Burke V, Mori TA, et al. The independent and combined effects of
aerobic exercise and dietary fish intake on serum lipids and glycemic control
in NIDDM. Diabetes Care 1997;20:913-21.,
- Sheehan JP, Wei IW, Ulchaker M, Tserng KY. Effect of high fiber intake in fish
oil-treated patients with non-insulin-dependent diabetes mellitus Am J Clin Nutr
1997;66:1183-7.
25. Stevens LJ, Zentall SS, Deck
JL, et al. Essential fatty acid metabolism in boys with attention-deficit
hyperactivity disorder. Am J Clin Nutr 1995;62:761–8.
26. Salem
N, Jr., Litman B, Kim HY, Gawrisch K.Mechanisms
of action of docosahexaenoic acid in the nervous system. Lipids. 2001;36(9):945-959.
- Chalon S, Vancassel S, Zimmer L, Guilloteau D, Durand G. Polyunsaturated
fatty acids and cerebral function: focus on monoaminergic neurotransmission.
Lipids. 2001;36(9):937-944.
- Larque E, Demmelmair H, Koletzko B. Perinatal
supply and metabolism of long-chain polyunsaturated fatty acids: importance for
the early development of the nervous system. Ann N Y Acad Sci. 2002;967:299-310.
- Uauy R, Hoffman DR, Peirano P, Birch DG, Birch EE. Essential
fatty acids in visual and brain development. Lipids. 2001;36(9):885-895.
27. Edwards R, Peet M, Shay J, Horrobin
D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell
membranes of depressed patients. J Affect Disord 1998;48:149-55.,
- Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels
in red blood cell membranes of depressive patients. Biol Psychiatry 1998;43:315-
- Maes M, Christophe A, Delanghe J, et al. Lowered omega3 polyunsaturated fatty
acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry
Res 1999;85:275-91.
- Emsley R, Myburgh C, Oosthuizen P, van Rensburg SJ. Randomized,
placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment
in schizophrenia. Am J Psychiatry. 2002;159(9):1596-1598.
- Fenton WS, Dickerson F, Boronow J, Hibbeln JR, Knable M. A
placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid)
supplementation for residual symptoms and cognitive impairment in schizophrenia.
Am J Psychiatry. 2001;158(12):2071-2074.
3g/zi
- Peet M, Horrobin DF. A
dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients
with persistent schizophrenic symptoms. J Psychiatr Res. 2002;36(1):7-18.
1g depresie ; 2g-3g/zi schizofr
28. de
Bravo MG, de Antueno RJ, Toledo J, et al. Effects of an eicosapentaenoic and
docosahexaenoic
acid concentrate on a human lung carcinoma grown in nu de mice. Lipids
1991;26:866–70.,
- Bougnoux P, Germain E, Hubert B, et al. Cytotoxic drugs efficacy correlates
with adiposte tissue docosahexanenoic level in locally advanced breast carcinoma.
Br J Cancer
1999;79:1765-9.
29. Dupuis F, Desplat V, Praloran V, Denizot Y. Effects of lipidic mediators
on the growth of human myeloid and erythroid marrow progenitors. Laboratoire
d'Hématologie Expérimentale, Faculté de Médecine, Lúnoges, France. J Lipid
Mediat Cell Signal. 1997 Jul;16(3):117-25.
30. Varney ME, Hardman WE, Sollars VE. Omega 3 fatty acids reduce myeloid progenitor
cell frequency in the bone marrow of mice and promote progenitor cell differentiation.
Department of Biochemistry and Microbiology, Marshall University School of Medicine,
Huntington, WV 25755, USA. Lipids Health Dis. 2009 Mar 18;8:9.
31. Karmali RA. Historical perspective and potential use of n-3 fatty acids
in therapy of cancer cachexia. Bryan Cave, New York, New York, USA. Nutrition.
1996
Jan;12(1 Suppl):S2-4.
|
Ulei de peste cu continutul de acizii grasi cu catena lunga eicosapentaenoic (EPA; 20:5n-3) si docosahexaenoic (DHA; 22:6n-3) sunt componenti de baza al uleiului de peste, importanti in dezvoltarea timpurie a copiilor, in principal a tesuturilor neurale si cresterea capacitatii de memorare la copii.